Organization · Venture Capital
Delphinus Venture Capital
Delphinus Venture Capital is a Danish venture capital firm based in Aarhus, focusing on research-driven and technology-intensive startups. It operates an €80 million evergreen fund, investing from pre-seed to growth stages.
Overview
What Delphinus Venture Capital does
What Delphinus Venture Capital is
Delphinus Venture Capital is a Danish venture capital firm based in Aarhus, focusing on research-driven and technology-intensive startups. It operates an €80 million evergreen fund, investing from pre-seed to growth stages.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2025
- Approximate age
- About 1 year
- Structured capabilities
- Funder
- Last reviewed
- April 29, 2026
Official channels
Find Delphinus Venture Capital elsewhere
Open the official website or a supported primary organization account.
Capability profile
Delphinus Venture Capital as a funder
Investment thesis
Delphinus invests in founders turning research into products with durable impact and technical defensibility, focusing on scalable research-based solutions that address long-term global challenges.
Focus narrative
Delphinus Venture Capital specializes in providing capital to startups that are developing innovative solutions to complex global challenges. The firm focuses on sectors such as food & agriculture, health & longevity, defence & security, energy & bioeconomy, and deep tech, ensuring that investments are made in companies with defensible technical moats and research-based foundations.
Value beyond capital
Delphinus Venture Capital adds value to its portfolio companies by providing patient capital, strategic guidance, and access to a robust network within the Danish and European startup ecosystems. The firm is positioned close to key research institutions, facilitating collaboration and innovation.
Focus and fit
- Stages
- Pre-seed · Seed · Growth Equity
- Regions
- Europe
Availability
- Currently deploying
- Yes
Portfolio and track record
Portfolio context
Decameal: A foodtech company converting invasive shore crabs into sustainable protein for the feed industry. EtOH Spirits: A technology company using patented methods for accelerated maturation of spirits. REDUCED: A foodtech company upcycling food side streams into clean-label ingredients. Kvantify: A deep-tech company developing software for early-stage drug discovery. Cordulus: An AI weather-data company providing hyperlocal forecasts for agriculture and energy. MedicQuant: A MedTech company focused on rapid diagnostics for acute stroke care. LevitaCare: A MedTech company developing support solutions for pelvic-floor recovery post-childbirth. Ora Biotics: A foodtech company creating targeted prebiotic ingredients for gut health. Cystotech: A MedTech company developing AI-based diagnostics for bladder cancer.
Common questions
What to know about Delphinus Venture Capital
Upseed classifies Delphinus Venture Capital under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 29, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.